Posted in | News | Biofuels

AREVA Invests In Bio-Coal

The AREVA group, a major player in renewable energies, has announced the acquisition of a technology enabling the production of bio-coal.

Based on the Thermya* torrefaction process, this unique technology, currently being deployed commercially, produces plant fuel from biomass which can replace fossil coal used in the production of thermal energy and electricity.

This operation enables AREVA to consolidate its position as a solutions provider for energy with less CO2. It is in line with the group’s strategy to broaden its offer in the field of renewable energies by placing a stronger emphasis on technology.

Based in the southwest of France, a team of around twenty people already forms part of this activity. Luc Oursel, President and CEO of AREVA, declared: “This acquisition strengthens our position in the field of renewable energies, and establishes AREVA on the global bio-coal market, which has considerable potential. Thanks to the acquisition of this unique torrefaction technology, and on the strength of its subsidiary AREVA Bioenergy 35 years of experience, the group is particularly well-placed to capture a significant share of the bio-coal market.” As an industrial pioneer in the field of bioenergy, AREVA is the leader on the market for turnkey biomass plants and has played a role in the installation of more than 5 000 MW of electric power worldwide.

* The torrefaction (or depolymerization) of biomass is a thermo-chemical process aiming to eliminate water and alter part of the organic matter of biomass to break down its fibers. Torrefied biomass (or bio-coal) offers a number of benefits, including high energy density, hydrophobia, and increased grindability.  

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.